Antonio Vita
A5036734827- Schizophrenia research and treatment
- Mental Health and Psychiatry
- Functional Brain Connectivity Studies
- Bipolar Disorder and Treatment
- Advanced Neuroimaging Techniques and Applications
- Treatment of Major Depression
- Tryptophan and brain disorders
- Mental Health Research Topics
- Mental Health Treatment and Access
- Autism Spectrum Disorder Research
- Obsessive-Compulsive Spectrum Disorders
- Genetics and Neurodevelopmental Disorders
- COVID-19 and Mental Health
- Genetic Associations and Epidemiology
- Personality Disorders and Psychopathology
- Child and Adolescent Psychosocial and Emotional Development
- Electroconvulsive Therapy Studies
- Psychosomatic Disorders and Their Treatments
- Long-Term Effects of COVID-19
- Attention Deficit Hyperactivity Disorder
- Psychopathy, Forensic Psychiatry, Sexual Offending
- Psychiatric care and mental health services
- Advanced MRI Techniques and Applications
- Diet and metabolism studies
- Neurological disorders and treatments
University of Brescia
2016-2025
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
2016-2025
GTx (United States)
2014-2024
Medizinische Hochschule Brandenburg Theodor Fontane
2024
Brescia University
2008-2023
University of Chieti-Pescara
2016-2022
University of Cagliari
2022
Azienda Ospedaliera Fatebenefratelli e Oftalmico
2022
University of Padua
2020
ASST Fatebenefratelli Sacco
2013
In people suffering from schizophrenia, major areas of everyday life are impaired, including independent living, productive activities and social relationships. Enhanced understanding factors that hinder real-life functioning is vital for treatments to translate into more positive outcomes. The goal the present study was identify predictors in with assess their relative contribution. Based on previous literature clinical experience, several were selected grouped three categories:...
<h3>Importance</h3> Enhanced understanding of factors associated with symptomatic and functional recovery is instrumental to designing personalized treatment plans for people schizophrenia. To date, this the first study using network analysis investigate associations among cognitive, psychopathologic, psychosocial variables in a large sample community-dwelling individuals <h3>Objective</h3> assess interplay psychopathologic variables, cognitive dysfunctions, capacity, personal resources,...
<h3>Importance</h3> This article briefly reports the experience of mental health services and lessons learned during coronavirus disease 2019 (COVID-19) crisis. In particular, this report offers opportunities to build on gained in managing COVID-19 emergency Departments Mental Health Addiction (DMHAs) Lombardy, wealthiest Italian region, which has approximately 10 million inhabitants. <h3>Observations</h3> Italy a National System divided into 134 DMHAs, 27 are Lombardy. 4 weeks after...
The goal of schizophrenia treatment has shifted from symptom reduction and relapse prevention to functional recovery; however, recovery rates remain low. Prospective identification variables associated with real-life functioning domains is essential for personalized integrated programs.To assess whether baseline illness-related variables, personal resources, context-related factors are work skills, interpersonal relationships, everyday life skills at 4-year follow-up.This multicenter...
Bipolar depression accounts for most of the disease duration in type I and II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals do not respond to first-line therapeutic resulting treatment-resistant (B-TRD). Esketamine, S-enantiomer ketamine, has recently been approved (TRD), but no data are available on its use B-TRD.To compare efficacy esketamine two samples unipolar TRD, providing preliminary indications effectiveness B-TRD. Secondary outcomes...
We completed a systematic genome-wide search for evidence of loci linked to schizophrenia using collection 70 pedigrees containing multiple affected individuals according three phenotype classifications: only (48 pedigrees; sib-pairs); plus schizoaffective disorder (70 101 and broad category consisting schizophrenia, disorder, paranoid or schizotypal personality psychosis not otherwise specified (NOS), delusional brief reactive 111 sib-pairs). All families contained at least one individual...
OBJECTIVE: Some genome-wide scans and association studies for schizophrenia susceptibility genes have yielded significant positive findings, but there is disagreement between on their locations, no mutation has yet been found in any gene. Since a complex disorder, study with sufficient power to detect locus small or moderate gene effect necessary. METHOD: In scan of 382 sibling pairs diagnosis schizoaffective 396 highly polymorphic markers spaced approximately 10 centimorgans apart...
In response to reported schizophrenia linkage findings on chromosomes 3, 6 and 8, fourteen research groups genotyped 14 microsatellite markers in an unbiased, collaborative (New) sample of 403–567 informative pedigrees per marker, the Original which produced each finding (the Johns Hopkins University 46–52 for 3 Medical College Virginia 156–191 chromosome 6). Primary planned analyses (New sample) were two-point heterogeneity lod score (lod2) tests (dominant recessive affected-only models),...